Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Sep;35(3):152-9.
doi: 10.1016/j.krcp.2016.07.001. Epub 2016 Jul 14.

Plasma endocan level and prognosis of immunoglobulin A nephropathy

Yu Ho Lee  1 , Jin Sug Kim  1 , Se-Yun Kim  1 , Yang Gyun Kim  1 , Ju-Young Moon  1 , Kyung-Hwan Jeong  1 , Tae Won Lee  1 , Chun-Gyoo Ihm  1 , Sang-Ho Lee  1
Affiliations

Plasma endocan level and prognosis of immunoglobulin A nephropathy

Yu Ho Lee et al. Kidney Res Clin Pract. 2016 Sep.

Abstract

Background: Endocan, previously called endothelial cell-specific molecule-1, is a soluble proteoglycan that is secreted from vascular endothelial cells. Elevated plasma endocan levels were shown to be associated with poor cardiovascular outcomes in patients with chronic kidney disease (CKD). We investigated the clinical relevance of plasma and urine endocan levels in patients with immunoglobulin A nephropathy (IgAN).

Methods: Sixty-four patients with IgAN and 20 healthy controls were enrolled in this study. Plasma and urine endocan levels were measured. Clinical parameters, pathologic grades, and renal outcomes were compared among subgroups with different plasma and urine endocan levels.

Results: Both plasma and urine endocan levels were significantly higher in patients with IgAN than in controls. Elevated serum phosphorus and C-reactive protein were independent determinants for plasma endocan, and elevated C-reactive protein was also an independent determinant for urine endocan levels in multivariate analysis. Plasma endocan level was not significantly different across CKD stages, but patients with higher plasma endocan levels showed adverse renal outcome. Urine endocan levels were also elevated in patients with poor renal function. Cox proportional hazard models showed that high plasma endocan was an independent risk factor for CKD progression after adjusting for the well-known predictors of outcome in patients with IgAN.

Conclusion: This study suggested that plasma endocan might be useful as a prognostic factor in patients with IgAN.

Keywords: Endocan; Endothelial cell–specific molecule-1; Immunoglobulin A nephropathy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Correlation analysis between plasma endocan and urine endocan level.
Figure 2
Figure 2
Box-and-whisker plots. Plasma (A) and urine (B) endocan levels are shown according to H. S. Lee pathologic grading.
Figure 3
Figure 3
Renal outcomes according to plasma (A) and urine (B) endocan levels.
See this image and copyright information in PMC

References

    1. Woo K.T., Chan C.M., Chin Y.M., Choong H.L., Tan H.K., Foo M., Anantharaman V., Lee G.S., Chiang G.S., Tan P.H., Lim C.H., Tan C.C., Lee E., Tan H.B., Fook-Chong S., Lau Y.K., Wong K.S. Global evolutionary trend of the prevalence of primary glomerulonephritis over the past three decades. Nephron Clin Pract. 2010;116:c337–c346. - PubMed
    1. Geddes C.C., Rauta V., Gronhagen-Riska C., Bartosik L.P., Jardine A.G., Ibels L.S., Pei Y., Cattran D.C. A tricontinental view of IgA nephropathy. Nephrol Dial Transplant. 2003;18:1541–1548. - PubMed
    1. Wakai K., Kawamura T., Endoh M., Kojima M., Tomino Y., Tamakoshi A., Ohno Y., Inaba Y., Sakai H. A scoring system to predict renal outcome in IgA nephropathy: from a nationwide prospective study. Nephrol Dial Transplant. 2006;21:2800–2808. - PubMed
    1. Berthoux F., Mohey H., Laurent B., Mariat C., Afiani A., Thibaudin L. Predicting the risk for dialysis or death in IgA nephropathy. J Am Soc Nephrol. 2011;22:752–761. - PMC - PubMed
    1. Tomioka M., Hiromura K., Sakairi T., Takeuchi S., Maeshima A., Kaneko Y., Kuroiwa T., Takeuchi T., Nojima Y. Nestin is a novel marker for renal tubulointerstitial injury in immunoglobulin A nephropathy. Nephrology (Carlton) 2010;15:568–574. - PubMed